Since cox-2 expression was not detected in the uveal tumor cells from RET mice and PGE2 levels remained unchanged in CLND mice regardless of celecoxib treatment, it is likely that celecoxib exerts its anti-tumor effects in our model via a cox-2 independent pathway. This evidence concerns the gene PTGS2 and neoplasm.